Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 118   

Articles published

JNJ 93.27 +1.18 (1.28%)
price chart
Johnson & Johnson marks Rs 650 crore more for Telangana
HYDERABAD: Global consumer healthcare, medical devices and pharmaceuticals giant Johnson & Johnson (J&J) is looking at investing another $100 million (Rs650 crore) to more than double its annual production capacity at its upcoming India's largest ...
Johnson & Johnson to bring 500 jobs to Tampa
Ernie Knewitz of Johnson & Johnson said the Tampa move adds to an already significant footprint for the company in Florida.
Tampa snags Johnson & Johnson corporate services headquarters with 500 jobs
Tampa wins Johnson & Johnson shared services North American HQ  Tampa Bay Business Journal
Johnson & Johnson goes to Silicon Valley with new hardware partnership
Johnson & Johnson JNJ -1.09% has partnered with PCH, a San Francisco hardware specialist, to help startups create innovative health care devices.
Learning From Johnson & Johnson's Time In The $60s
Johnson & Johnson is an excellent example of a company that continues to provide solid business performance year-in and year-out.
Johnson & Johnson (JNJ) Stock Up on Splenda Sale
"We rate JOHNSON & JOHNSON (JNJ) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Johnson & Johnson Will Sell Splenda Sweetener to Heartland Food  Bloomberg
Johnson & Johnson Rating Lowered to Buy at Vetr Inc. (JNJ)
Morgan Stanley set a $108.00 target price on shares of Johnson & Johnson and gave the company a “hold” rating in a report on Friday, May 15th.
Large Inflow of Money Witnessed in Johnson & Johnson  Money Flow Index
Johnson & Johnson Analyst Rating Update  News Watch International
Sophia knowledge management system poised for ROI at Johnson & Johnson
Consider Johnson & Johnson (J&J), a consumer health company, based in New Brunswick, N.J., that has decades of testing data on its products, such as skin irritation tests.
8 Things You Probably Don't Know About Johnson & Johnson
Healthcare conglomerate Johnson & Johnson (NYSE: JNJ ) is arguably the mantelpiece healthcare company all investors look up to.
Johnson & Johnson Offers High Returns and Stability for a Bargain
Johnson & Johnson was founded in 1886. The company is now the largest health care business in the world. The company has a market cap of $276.7 billion, generates over $70 billion a year in sales, and $16 billion a year in profits.
Johnson & Johnson Innovation Announces Collaboration on Immuno-Oncology ...
About Johnson & Johnson Innovation Johnson & Johnson Innovation LLC is working to accelerate scientific innovation at all stages of development worldwide to deliver cutting-edge solutions that solve unmet needs for patients.